Long-term safety of tiotropium/olodaterol in older patients with moderate-to-very-severe COPD in the TONADO® studies

Older patients with chronic obstructive pulmonary disease (COPD) may be at increased risk of adverse events (AEs) due to decreased protective organ function and increased comorbidities. TONADO® 1 + 2 were replicate, randomized, double-blind, parallel-group, 52-week, Phase III trials comparing the ef...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferguson, Gary T., Maltais, François, Karpel, Jill, Bothner, Ulrich, Kloer, Isabel, Trampisch, Matthias, Buhl, Roland
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7719164/
https://www.ncbi.nlm.nih.gov/pubmed/33277507
http://dx.doi.org/10.1038/s41533-020-00212-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7719164/
https://www.ncbi.nlm.nih.gov/pubmed/33277507
http://dx.doi.org/10.1038/s41533-020-00212-w

Ejemplares similares